ArticleScientific reports2025
Toxicity analysis of gold nanoparticle formulations used for intraocular applications.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Amorphous selenium nanoparticles: synthesis strategies and multifunctional applications.RSC advances · 2026Review
- Bioengineered systems to exploit tumor microenvironment metabolism.Trends in cancer · 2026Review
- An LSPR-Active AuNP-Silicone Hydrogel Contact Lens for Continuous Ocular Strain Sensing: From Engineering Design to In Vivo Validation.Biosensors · 2026Article
- Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications.Journal of nanobiotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gold nanoparticles (AuNPs) possess unique properties for various biological and intraocular applications. In retina research, AuNPs hold promise for therapeutic intervention, drug delivery, and photoreceptor replacement, but their potential toxicity is an area of concern. This study assesses the toxicity of AuNPs formulations suitable for photoreceptor replacement in retinal cells and tissue. Three different gold formulations were studied. One in the form of a single gold nanoparticle with citrate groups (AuNP), an AuNP coated with linkers and superhydrophobic layers (NC), and the NCs mounted on a BaTiO3 nanocore with a high dielectric constant (BTNC). Proliferation assays (PA) and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays with different concentrations of AuNPs, NC, and BTNC were conducted on human retinal endothelial cell (hREC) cultures. Following intravitreal injection (IVI) of nanoparticles in wild type (WT) mice, function was evaluated with electroretinography (ERG), structural changes through optical coherence tomography (OCT), and vascular change with Isolectin B4 (IB4) postmortem staining. No significant cell death or decreased growth were observed at concentrations below 100ppm in vitro (p-value > 0.05). Mice were examined before and after IVI with nanoparticles, and no major changes were seen. These findings indicate that AuNPs can cause a transient change in the electrophysiology of normal tissue and may impose structural changes at higher concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.